カテゴリ： MarketLine, シンガポール, 企業調査

Temasek Holdings (Private) Ltd：企業の戦略・SWOT・財務分析

◆英語タイトル：Temasek Holdings (Private) Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3556
◆発行会社（調査会社）：MarketLine
◆発行日：2019年12月
◆ページ数：60
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：シンガポール
◆産業分野：Financial Services
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Temasek Holdings (Private) Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Temasek Holdings (Private) Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Temasek Holdings (Private) Ltd (Temasek) is an investment company. The company makes investments in diversified range of industries. The company invests in industries such as media, transportation, real estate, energy and resources, life sciences, agribusiness, multi-sector funds, telecommunication, technology, consumer and financial services. Its diversified portfolio comprises investments in the principal geographic regions including Singapore, China, Rest of Asia, Australia, New Zealand, North America, Europe, Latin America, and Africa, Central Asia and the Middle East. The company operates through its offices located in Singapore, Brazil, India, China, Mexico, the US, the UK and Vietnam. The company is owned by the government of Singapore. Temasek is headquartered in Singapore City, Singapore.

Scope

- Detailed information on Temasek Holdings (Private) Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Temasek Holdings (Private) Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Temasek Holdings (Private) Ltd including a breakdown and examination of key business segments
- Intelligence on Temasek Holdings (Private) Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Temasek Holdings (Private) Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Temasek Holdings (Private) Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Temasek Holdings (Private) Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Temasek Holdings (Private) Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Temasek Holdings (Private) Ltd: Company Overview
Temasek Holdings (Private) Ltd: Overview and Key Facts
Temasek Holdings (Private) Ltd: Overview
Temasek Holdings (Private) Ltd: Key Facts
Temasek Holdings (Private) Ltd: Key Employees
Temasek Holdings (Private) Ltd: Key Employee Biographies
Temasek Holdings (Private) Ltd: Major Products and Services
Temasek Holdings (Private) Ltd: Company History
Temasek Holdings (Private) Ltd: Management Statement
Temasek Holdings (Private) Ltd: Locations and Subsidiaries
Temasek Holdings (Private) Ltd: Key Competitors
Temasek Holdings (Private) Ltd: Company Analysis
Temasek Holdings (Private) Ltd: Business Description
Temasek Holdings (Private) Ltd: SWOT Analysis
Temasek Holdings (Private) Ltd: SWOT Overview
Temasek Holdings (Private) Ltd: Strengths
Temasek Holdings (Private) Ltd: Weaknesses
Temasek Holdings (Private) Ltd: Opportunities
Temasek Holdings (Private) Ltd: Threats
Temasek Holdings (Private) Ltd: Corporate Financial Deals Activity
Temasek Holdings (Private) Ltd: Financial Deals Overview
Temasek Holdings (Private) Ltd: Targets and Partners
Temasek Holdings (Private) Ltd: Top Deals 2015 – 2019YTD*
Temasek Holdings (Private) Ltd: Advisors
Temasek Holdings (Private) Ltd: Top Legal Advisors
Temasek Holdings (Private) Ltd: Top Financial Advisors
Temasek Holdings (Private) Ltd: Mergers and Acquisitions
Temasek Holdings (Private) Ltd: Corporate Venturing
Temasek Holdings (Private) Ltd: Capital Raising
Temasek Holdings (Private) Ltd: Partnership
Temasek Holdings (Private) Ltd: Divestments
Temasek Holdings (Private) Ltd: Recent Developments
Temasek Holdings (Private) Ltd: News and Events Summary
Temasek Holdings (Private) Ltd: Business Expansion
Temasek Holdings (Private) Ltd: Contracts
Temasek Holdings (Private) Ltd: Corporate Governance
Temasek Holdings (Private) Ltd: Financial Deals
Temasek Holdings (Private) Ltd: Financial Performance
Temasek Holdings (Private) Ltd: Regulatory and Legal Events
Temasek Holdings (Private) Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Temasek Holdings (Private) Ltd: Key Facts
Table 2: Temasek Holdings (Private) Ltd: Key Employees
Table 3: Temasek Holdings (Private) Ltd: Company History
Table 4: Temasek Holdings (Private) Ltd: Locations and Subsidiaries
Table 5: Temasek Holdings (Private) Ltd: Key Competitors
Table 6: Temasek Holdings (Private) Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Temasek Holdings (Private) Ltd: M&A Activity by Geography (TTM*)
Table 8: Temasek Holdings (Private) Ltd: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: Temasek Holdings (Private) Ltd: M&A Average Deal Size - Value (US$m)
Table 10: Temasek Holdings (Private) Ltd: Targets and Partners
Table 11: Temasek Holdings (Private) Ltd: Top Deals 2015 - 2019YTD*
Table 12: Temasek Holdings (Private) Ltd: Legal Advisor Ranking by Value (US$m)
Table 13: Temasek Holdings (Private) Ltd: Financial Advisor Ranking by Value (US$m)
Table 14: Temasek Holdings (Private) Ltd: M&A Volume and Value Trend (2015 - YTD*2019)
Table 15: Temasek Holdings (Private) Ltd: M&A Activity by Geography (2015 - YTD*2019)
Table 16: Temasek Holdings (Private) Ltd: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 17: Temasek Holdings (Private) Ltd: Corporate Venturing by Geography (2015 - YTD*2019)
Table 18: Temasek Holdings (Private) Ltd: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 19: Temasek Holdings (Private) Ltd: Capital Raising by Deal Type (2015 - YTD*2019)
Table 20: Temasek Holdings (Private) Ltd: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 21: Temasek Holdings (Private) Ltd: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 22: Temasek Holdings (Private) Ltd: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 23: Temasek Holdings (Private) Ltd: Divestments by Geography (2015 - YTD*2019)
Table 24: Temasek Holdings (Private) Ltd: News and Events Summary
Table 25: Temasek Holdings (Private) Ltd: Business Expansion
Table 26: Temasek Holdings (Private) Ltd: Contracts
Table 27: Temasek Holdings (Private) Ltd: Corporate Governance
Table 28: Temasek Holdings (Private) Ltd: Financial Deals
Table 29: Temasek Holdings (Private) Ltd: Financial Performance
Table 30: Temasek Holdings (Private) Ltd: Regulatory and Legal Events
Table 31: Temasek Holdings (Private) Ltd: Strategy and Operations

★海外企業調査レポート[Temasek Holdings (Private) Ltd：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • H2O Retailing Corporation：企業の戦略・SWOT・財務情報
    H2O Retailing Corporation - Strategy, SWOT and Corporate Finance Report Summary H2O Retailing Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Keysight Technologies Inc：企業の戦略・SWOT・財務情報
    Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • OCON Medical Ltd：企業の製品パイプライン分析2018
    Summary OCON Medical Ltd (OCON Medical) is a manufacturer of women’s health products. The company provides leverages intrauterine technology to develop contraceptive intrauterine devices for women. It develops IUB SCu300, an advanced intrauterine device that is compatible with the uterine cavity. OC …
  • Bucher Industries AG：企業の戦略・SWOT・財務情報
    Bucher Industries AG - Strategy, SWOT and Corporate Finance Report Summary Bucher Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • HeidelbergCement AG：戦略・SWOT・企業財務分析
    HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report Summary HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Adocia SAS (ADOC)：製薬・医療：M&Aディール及び事業提携情報
    Summary Adocia SAS (Adocia) is a biotechnology company that discovers and develops therapeutic proteins. The company provides products such as formulation of PDGF-BB for the treatment of diabetic foot ulcers. It offers novel insulin formulations for the treatment of diabetes and BioChaperone Lispro …
  • Biovista Inc-製薬・医療分野：企業M&A・提携分析
    Summary Biovista Inc (Biovista) is a drug development company that provides COSS platform technology support in uncovering non-obvious correlations between drugs. The company’s products are used for the treatment of neurodegenerative diseases, epilepsy, oncology and orphan diseases. It offers servic …
  • GW Pharmaceuticals Plc (GWPH)：医療機器：M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • BrightPath Early Learning Inc.：企業の戦略的SWOT分析
    BrightPath Early Learning Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • China Development Financial Holding Corporation：企業の戦略・SWOT・財務情報
    China Development Financial Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary China Development Financial Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Haisco Pharmaceutical Group Co Ltd (002653)：製薬・医療：M&Aディール及び事業提携情報
    Summary Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations. The company offers parenteral nutrition drugs, first-aid drugs, antibiotics, anesthetic agents, nervous system drugs, digestive sy …
  • Bank Frick & Co. AG：企業の戦略・SWOT・財務情報
    Bank Frick & Co. AG - Strategy, SWOT and Corporate Finance Report Summary Bank Frick & Co. AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • M. A. Mortenson Company：企業の戦略・SWOT・財務情報
    M. A. Mortenson Company - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Orion Corp (ORNBV)：医療機器：M&Aディール及び事業提携情報
    Summary Orion Corp (Orion) is a developer of pharmaceuticals and diagnostic tests. The company develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients (APIs) and diagnostic tests. It focuses on developing pharmaceutical products for central nervous …
  • Idexx Laboratories Inc (IDXX)：企業の財務・戦略的SWOT分析
    Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Kallpa Generacion SA：発電所・企業SWOT分析
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Cannabics Pharmaceuticals Inc (CNBX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated cellular imaging and analysis platform designed …
  • Nemus Bioscience Inc (NMUS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Nemus Bioscience Inc (Nemus Bioscience) is a life-science and biopharmaceutical company that offers discovering, developing and commercializing cannabinoid-based therapeutics. The company’s drug pipeline products include NB1111, NB1222, NB2111, NB2222 and Cannabinoid platform NB3111. Its can …
  • Genocea Biosciences Inc (GNCA)：企業の財務・戦略的SWOT分析
    Summary Genocea Biosciences Inc (Genocea), formerly Genocea Inc is a biopharmaceutical company develops targeted vaccines and immunotherapies for the treatment of cancer. The company’s pipeline products include Gen-009 and Gen-010, a neoantigen cancer vaccine; Gen-011 is an adoptive T cell therapy. …
  • Aarti Drugs Ltd (AARTIDRUGS)：企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and specialty chemicals. Its active pharmaceutical in …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆